HP and myocardial infarction: Importantly, a number of recent studies implicate the absolute amount and quality of the HP gene product as an independent risk factor for a multitude of diseases including: diabetes [32]; atherosclerosis [33]; poor clinical outcome following myocardial infarction [28], [34]; and percutaneous coronary interventions [34], [35].